CHILDRENS HOSPITAL OF MICHIGAN
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $232K
- Transactions
- 134
- Companies
- 19
- Average per transaction
- $1,728
Who reported the payments
| Merck | $104,273 |
| PTC Therapeutics, Inc. | $26,119 |
| Novo Nordisk AS | $21,412 |
| Insmed, Inc. | $19,350 |
| Agios Pharmaceuticals, Inc. | $18,994 |
| Diagnostica Stago, Inc | $11,633 |
| Stryker | $8,730 |
| Nabriva Therapeutics, PLC | $5,878 |
| AbbVie | $5,284 |
| National Marrow Donor Program | $3,550 |
| C. R. Bard, Inc. & Subsidiaries | $2,378 |
| Abbott | $2,150 |
| Ortho-clinical Diagnostics, Inc. | $1,130 |
| Welch Allyn | $256 |
| Oticon Medical, LLC | $150 |
| Saol Therapeutics Inc. | $135 |
| Olympus America Inc. | $121 |
| Johnson & Johnson | $69 |
| Amgen | $7 |